Application of Electronic Endoscope in Fetal Distress
The New Application of Electronic Endoscope in the Visual Diagnosis and Treatment of Intrauterine Fetal Distress During Labor
1 other identifier
interventional
15
1 country
1
Brief Summary
Fetal distress is a common emergency in obstetrics, which refers to the combined symptoms of fetal health and life in utero due to acute or chronic hypoxia, with an incidence of 2.7% to 38.5%. Fetal distress is mainly related to abnormal amniotic fluid, umbilical cord entanglement and compression, which is an important reason for the increase of cesarean section rate during delivery. At present, the diagnosis of fetal distress mainly relies on electronic monitoring of fetal heart, and the false positive rate is high. Intrauterine pressure catheter has not been widely used because of the little effect of intrauterine treatment and the increase of infection. Endoscopy has been widely used in the diagnosis and treatment of various specialties at present, but the diagnosis and treatment during childbirth are still in a blind area. The characteristics of endoscopic visualization provide a new idea for the diagnosis and treatment of fetal distress during delivery, especially for the etiological diagnosis and treatment of umbilical cord factors. The use of intraauterine endoscope during delivery can make up for the defects of intrauterine pressure catheter, realize the visual diagnosis of the causes of fetal distress such as oligoamniotic fluid, meconium contamination of amniotic fluid, umbilical cord compression caused by entangling and true junction, etc. At the same time, it can also improve the intrauterine environment by perfusion of saline for the causes of fetal embarrassment, correct fetal distress, and extend the observation time during labor. It is beneficial to reduce caesarean section during labor.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 12, 2024
CompletedFirst Posted
Study publicly available on registry
September 23, 2024
CompletedStudy Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 25, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 25, 2026
ExpectedSeptember 23, 2024
September 1, 2024
11 months
August 12, 2024
September 19, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
fetal distress rate
fetal distress rate during first stage of labor
through study completion, an average of 1 year
Secondary Outcomes (4)
vaginal delivery rate
through study completion, an average of 1 year
Incidence of maternal infection
through study completion, an average of 1 year
Neonatal asphyxia rate
through study completion, an average of 1 year
neonatal NICU admission rate
through study completion, an average of 1 year
Study Arms (1)
fetal distress
EXPERIMENTALInterventions
Intrauterine bronchoscopy application for fetal distress during labor
Eligibility Criteria
You may qualify if:
- Subjects aged 20-45 years with single pregnancy;
- Intrauterine fetal distress occurs during labor (during the first stage of labor), and the fetal membrane was already broken;
- Fetal heart monitoring category II, after stopping oxytocin, oxygen inhalation, change of position, intravenous fluid and other measures can not improve;
- Understand the research procedures, be able to follow the procedures of the research protocol, and voluntarily sign a written consent.
You may not qualify if:
- Type III fetal heart monitoring for pregnant women who require emergency c-section
- Pregnant women with GBS positive
- Pregnant women suspected of chorioamniotic infection
- Pregnant women have signs of reproductive system infection (vaginal inflammation, cervicitis, uterine infection)
- Pregnant women suspected of uterine rupture
- Pregnant women with abnormal contractions: excessive strong contractions
- Check the fetus for serious deformities during pregnancy
- Check pregnant women with serious abnormal functions of cardiovascular system, urinary system, digestive system, reproductive system and other organs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2024
First Posted
September 23, 2024
Study Start
October 1, 2024
Primary Completion
August 25, 2025
Study Completion (Estimated)
August 25, 2026
Last Updated
September 23, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share